NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled